Oncology & Cancer

Trial shows promise for new antibody cancer treatment

The first ever clinical trial of a new class of immunotherapy for cancer has shown promising results that could benefit patients who do not respond to existing cancer treatments.

Neuroscience

Neurotransmitter orexin influences pupil size, research shows

The way the brain regulates pupil size is different from previously thought: fundamentally responsible is the neurotransmitter orexin, as researchers at ETH Zurich have now shown. This discovery could well alter our understanding ...

Oncology & Cancer

Fecal transplants show promise in improving melanoma treatment

In a world-first clinical trial published in the journal Nature Medicine, a multi-center study from Lawson Health Research Institute, the Centre hospitalier de l'Université de Montréal (CHUM) and the Jewish General Hospital ...

Neuroscience

ClearTau: A new tool for studying neurodegenerative diseases

EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer's disease and other neurodegenerative diseases. The breakthrough may speed up ...

Medical research

Researchers test AI-powered chatbot's medical diagnostic ability

In a recent experiment published in JAMA, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) tested one well-known publicly available chatbot's ability to make accurate diagnoses in challenging medical ...

page 5 from 40